Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Sarcoma 1Head & Neck 1

Conditions

Breast Neoplasms 3Wound Infection 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Cefazolin × Breast × Clear all
NCT02395614 2022-01-26

Surgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic Irrigation

Vanderbilt University Medical Center

Phase NA Completed
88 enrolled 10 charts
Breast

Breast Neoplasms

NCT04818931 2021-03-29

Does a Preoperative Prophylactic Antibiotic Reduce Surgical Site Infection Following Wire-localized Lumpectomy

CHU de Quebec-Universite Laval

Phase NA Completed
326 enrolled
Breast

Breast Neoplasms

NCT02809729 2017-10-25

Antibiotic Prophylaxis in Oncological Surgery of Breast

Universidade do Vale do Sapucai

Phase NA Completed
124 enrolled
Breast

Breast Neoplasms, Wound Infection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡